These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37289868)

  • 1. No trip needed for psychedelics to lift mood?
    O'Grady C
    Science; 2023 Jun; 380(6649):999. PubMed ID: 37289868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.
    Moliner R; Girych M; Brunello CA; Kovaleva V; Biojone C; Enkavi G; Antenucci L; Kot EF; Goncharuk SA; Kaurinkoski K; Kuutti M; Fred SM; Elsilä LV; Sakson S; Cannarozzo C; Diniz CRAF; Seiffert N; Rubiolo A; Haapaniemi H; Meshi E; Nagaeva E; Öhman T; Róg T; Kankuri E; Vilar M; Varjosalo M; Korpi ER; Permi P; Mineev KS; Saarma M; Vattulainen I; Casarotto PC; Castrén E
    Nat Neurosci; 2023 Jun; 26(6):1032-1041. PubMed ID: 37280397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.
    Jalal B
    Psychopharmacology (Berl); 2018 Nov; 235(11):3083-3091. PubMed ID: 30288594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based discovery of nonhallucinogenic psychedelic analogs.
    Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
    Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.
    Dos Santos RG; Hallak JE; Baker G; Dursun S
    J Psychopharmacol; 2021 Apr; 35(4):453-458. PubMed ID: 33740877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
    Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
    Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
    Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinogens and Serotonin 5-HT
    López-Giménez JF; González-Maeso J
    Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.
    Pallavicini C; Vilas MG; Villarreal M; Zamberlan F; Muthukumaraswamy S; Nutt D; Carhart-Harris R; Tagliazucchi E
    Neuroimage; 2019 Oct; 200():281-291. PubMed ID: 31247301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.
    Singleton SP; Luppi AI; Carhart-Harris RL; Cruzat J; Roseman L; Nutt DJ; Deco G; Kringelbach ML; Stamatakis EA; Kuceyeski A
    Nat Commun; 2022 Oct; 13(1):5812. PubMed ID: 36192411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychedelics without hallucinations?
    Service RF
    Science; 2022 Jan; 375(6579):370. PubMed ID: 35084949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.
    Halberstadt AL
    Behav Brain Res; 2015 Jan; 277():99-120. PubMed ID: 25036425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Classic psychedelic drugs and their potential therapeutic effect].
    Bayat M
    Ugeskr Laeger; 2017 Sep; 179(37):. PubMed ID: 28918777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution of serotonin 5-HT
    Ibi D
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats.
    Malikowska-Racia N; Koniewski M; Golebiowska J; Popik P
    J Psychopharmacol; 2023 Nov; 37(11):1149-1156. PubMed ID: 37842884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
    Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
    Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
    Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD
    Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.
    Canal CE
    Handb Exp Pharmacol; 2018; 252():227-260. PubMed ID: 29532180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.